CD4 and inflammatory bowel disease: In order to investigate the involvement of HDACs in KCa3.1 transcription in the CD4+ T cells of IBD model mice, we examined the effects of the pan-HDAC inhibitor, vorinostat on the expression and activity of KCa3.1 in the CD4+ T cells of IBD model mice.